Partner Content Partner Content SMi’ 10th Annual Social Media in Pharma – Pfizer Exclusive S... Social Media in Pharma
Partner Content Partner Content How Doctors’ Conversations Differ From Private to Public Soc... ocial Media in Pharma
Partner Content Partner Content Driving Patient Engagement Through Powerful Social Strategie... SMi’s Social Media in Pharma
Partner Content Partner Content 7 Key Reasons to Attend Social Media in the Pharmaceutical I... SMi's 10th Annual Conference
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
